India, Nov. 10 -- The Government of India has issued a release:
The National Coordination Centre - Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission (IPC), participated in the tenth edition of the global #MedSafetyWeek campaign, held from 3-9 November 2025, along with 130 partner organisations worldwide.
Speaking at the occasion, Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, stated that, the research indicates that only 5-10% of all suspected side effects are reported globally. This means that we only see the tip of the iceberg, and that it may take longer to identify important safety issues. Through #MedSafetyWeek, we aim to make more people aware that their report matters.
By reporting suspe...